Advanced Therapy Medicinal Products (ATMPs) Outsourcing
France has carved out a unique niche in the outsourcing of Cell and Gene Therapies (ATMPs). Specialized hubs in clusters like Genopole (near Paris) and Lyonbiopôle provide specialized viral vector production and CAR-T cell manufacturing services.
These facilities offer "clean-room-as-a-service" models, allowing small biotech startups to outsource the most complex parts of their manufacturing without building their own multi-million dollar factories. This collaborative ecosystem has made France the preferred destination for US and Asian biotechs looking to enter the European market.
3 Views